Advertisement

Congenital Nemaline Myopathy Type 1

  • Corrado Angelini
Chapter

Abstract

Nemaline myopathy is a congenital myopathy whose hallmark is the histopathological feature of “rods” or “nemaline” bodies accumulated at the periphery of most fibers that, on electron microscopy, are formed by protein crystalline structures that derive from several constituents of sarcomeric Z-line, such as alpha-actinin, tropomyosin, nebulin, and actin. The disease is therefore genetically heterogeneous, since many genes and proteins are responsible of different forms. The first gene identified in families with autosomal dominant nemaline myopathy was TPM3, encoding for alpha-tropomyosin-3 [1, 2]. Mutations in the same TPM3 gene may also originate different forms of congenital myopathies: “cap disease” [3, 4] which is characterized histopathologically by peculiar cap-like inclusions at the periphery of muscle fibers and congenital fiber-type disproportion [5, 6] which is characterized by hypotrophy of type 1 muscle fibers. Recessive mutations in TPM3 gene may also cause nemaline myopathy [7], and it was suggested that patients with recessive mutations may have more severe phenotype than those with dominant gene mutations [2, 7, 8].

Keywords

Nemaline myopathy Alpha-tropomyosin-3 

References

  1. 1.
    Laing NG, Wilton SD, Akkari PA, et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet. 1995;9:75–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Pénisson-Besnier I, Monnier N, Toutain A, Dubas F, Laing N. A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study. Neuromuscul Disord. 2007;17:330–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Malfatti E, Schaeffer U, Chapon F, et al. Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene. Neuromuscul Disord. 2013;23:992–7.CrossRefPubMedGoogle Scholar
  4. 4.
    De Paula AM, Franques J, Fernandez C, et al. A TPM3 mutation causing cap myopathy. Neuromuscul Disord. 2009;19:685–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat. 2010;31:176–83.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Clarke NF, Kolski H, Dye DE, et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol. 2008;63:329–37.CrossRefPubMedGoogle Scholar
  7. 7.
    Tan P, Briner J, Boltshauser E, et al. Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord. 1999;9:573–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Marttila M, Lehtokari VL, Marston S, et al. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies. Hum Mutat. 2014;35:779–90.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Corrado Angelini
    • 1
  1. 1.IRCCS Fondazione S.Camillo HospitalUniversità di Padova, Dipartimento di Neuroscienze PadovaVeniceItaly

Personalised recommendations